An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies

• Aurélie Prémaud ,

  * E-mail: aurelie.premaud@unilim.fr

  Affiliations INSERM, U850, Limoges, France, Univ. Limoges, UMR_S850, Limoges, France

  http://orcid.org/0000-0001-5004-5918

  ⨯
• Matthieu Filloux,

  Affiliations CHU Limoges, Service d’immunologie et immunogénétique, Limoges, France, CNRS, CRIBL, UMR 7276, Limoges, France

  ⨯
• Philippe Gatault,

  Affiliation CHU Tours, Service Néphrologie–et Immunologie Clinique, Tours, France

  ⨯
• Antoine Thierry,

  Affiliation CHU Poitiers, Service de Néphrologie-Hémodialyse-Transplantation rénale, Poitiers, France

  ⨯
• Matthias Büchler,

  Affiliation CHU Tours, Service Néphrologie–et Immunologie Clinique, Tours, France

  ⨯
• Eliza Munteanu,

  Affiliation CHU Limoges, Service de néphrologie, dialyse-transplantations, Limoges, France

  ⨯
• Pierre Marquet,

  Affiliations INSERM, U850, Limoges, France, Univ. Limoges, UMR_S850, Limoges, France, CHU Limoges, Service de pharmacologie, toxicologie et pharmacovigilance, Limoges, France

  ⨯
• Marie Essig ,

  Contributed equally to this work with: Marie Essig, Annick Rousseau

  Affiliations INSERM, U850, Limoges, France, Univ. Limoges, UMR_S850, Limoges, France, CHU Limoges, Service de néphrologie, dialyse-transplantations, Limoges, France

  ⨯
• Annick Rousseau

  Contributed equally to this work with: Marie Essig, Annick Rousseau

  Affiliations INSERM, U850, Limoges, France, Univ. Limoges, UMR_S850, Limoges, France

  ⨯